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 Background: Scleroderma is a chronic disorder, characterized by thickening and fibrosis of 
the skin and disruption of internal organs that affects global functioning and quality of life. 
Facial skin alterations have an impact on self-esteem and interfere with social interactions, 
with an association to psychological symptoms, especially depression. The aim of this study, 
in collaboration with a Canadian team and European Associations, intended to characterize 
the symptoms and the psychological problems in European patients with scleroderma.  
Methods: 563 participants from 13 European Countries;  484 (89%) female; 59 (11%) male; 
mean age: 49 (SD= 14.8); 93% caucasian; 68% married; 32% higher education  filled out the 
Patient Survey of Health Concerns and Research Priorities. (Scleroderma Society of Canada 
(SSC) and Canadian Scleroderma Research Group).The questionnaire has 11 Sections 
(Demographics, Diagnosis and Disease; Healthcare Services Utilization;  Healthcare 
Services Reimbursement;  Healthcare Services Reimbursement Needs;  Medical Care; 
Symptoms; Employment; Sensations; Physical Appearance; Commentaries). 
Results: the symptoms most commonly reported by patients are: joint pain, fatigue, 
Raynaud’s symptoms, muscle pain, hardening/tightening of the skin, difficulty sleeping, 
difficulty remember things and heartburn. 74% of participants reported that they show little 
interest or pleasure in performing tasks several days, more than half of the days or nearly 
every day. 72% feels down, depressed or hopeless, several days, more than half of the days 
or nearly every day. 72% Feel’s nervous, anxious, or on edge, more than half of the days or 
nearly every day. 40% reported the avoidance of activities because they feel that they will 
fail due to scleroderma related problems. 43% of participants have been diagnosed with 
diffuse scleroderma and 21% with CREST. 77% reported other medical conditions, the most 
frequent  being Esophageal dysfunction (56%). 100% of participants reported concern 
regarding the appearance of parts of their bodies, which they consider especially 
unattractive due to scleroderma. 64% of participants reported that scleroderma affects their 
ability to work, very much or extremely.  
Discussion and Conclusions: The results concerning the frequency and impact of symptoms 
were approximate to the results obtained in Canada. There was however some marked 
differences in psychological variables. The results of the European participants reached 
higher levels on issues of depression and anxiety. The results of this study indicate that all 
participants are concerned about the physical appearance due to scleroderma. These 
results emphasize the need of psychological intervention in patients with scleroderma in 
Europe. These results should be taken into consideration by the teams who follow these 
patients.  
 
